COVID-19 in Systemic Lupus Erythematosus patients treated with belimumab: a retrospective clinical study
Description
CONCLUSION: This study concluded that treatment with belimumab did not increase susceptibility to COVID-19 and beneficially alleviated the symptoms of COVID-19.